Swipe om te navigeren naar een ander artikel
Quality of life is an outcome often examined in treatment research contexts such as biomedical trials, but has been studied less often in alcohol use disorder (AUD) treatment. The importance of considering QoL in substance use treatment research has recently been voiced, and measures of QoL have been administered in large AUD treatment trials. Yet, the viability of popular QoL measures has never been evaluated in AUD treatment samples. Accordingly, the present manuscript describes a psychometric examination of and prospective changes in the World Health Organization Quality of Life measure (WHOQOL-BREF) in a large sample (N = 1383) of patients with AUD recruited for the COMBINE Study.
Specifically, we examined the construct validity (via confirmatory factor analyses), measurement invariance across time, internal consistency reliability, convergent validity, and effect sizes of post-treatment changes in the WHOQOL-BREF.
Confirmatory factor analyses of the WHOQOL-BREF provided acceptable fit to the current data and this model was invariant across time. Internal consistency reliability was excellent (α > .9) for the full WHOQOL-BREF for each timepoint; the WHOQOL-BREF had good convergent validity, and medium effect size improvements were found in the full COMBINE sample across time.
These findings suggest that the WHOQOL-BREF is an appropriate measure to use in samples with AUD, that the WHOQOL-BREF scores may be examined over time (e.g., from pre- to post-treatment), and the WHOQOL-BREF may be used to assess improvements in quality of life in AUD research.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: American Psychiatric Association. CrossRef
Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., … COMBINE Study Research Group. (2006). Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: A randomized controlled trial. The Journal of the American Medical Association, 295(17), 2003–2017.
Chen, F. F., Sousa, K. H., & West, S. G. (2005). Testing measurement invariance of second-order factor models. Structural Equation Modeling, 12(3), 471–492. CrossRef
Cheung, G. W., & Rensvold, R. B. (1999). Evaluating goodness-of-fit indexes for testing measurement invariance. Structural Equation Modeling, 9(3), 233–255.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Earlbaum Associates.
COMBINE Study Group. (2003). Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: Rationale and methods. Alcoholism, Clinical and Experimental Research, 27(7), 1107–1122. CrossRef
Curran, P. J., McGinley, J. S., Baurer, D. J., Hussong, A. M., Burns, A., Chassin, L., ... Zucker, R. (2014). A moderated nonlinear factor model for the development of commensurate measures in integrative data analysis. Multivariate Behavioral Research, 49, 214–231. doi: 10.1080/00273171.2014.889594.
Derogatis, L. R. (1993). BSI. Brief Symptom Inventory. Administration, Scoring, and Procedures Manual (3rd ed.) National Computer Systems, Inc., Minneapolis, MN.
Donovan, D. M., Anton, R. F., Miller, W. R., Longabaugh, R., Hosking, J. D., & Youngblood, M. (2008). Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes. Journal of Studies on Alcohol and Drugs, 69, 5–13. doi: 10.15288/jsad.2008.69.5. CrossRefPubMed
Donovan, D. M., Bigelow, G. E., Brigham, G. S., Carroll, K. M., Cohen, A. J., Gardin, J. G., … Wells, E. A. (2012). Primary outcome indices in illicit drug dependence treatment research: Systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction, 107(4), 694–708.
Donovan, D., Mattson, M. E., Cisler, R. A., Longabaugh, R., & Zweben, A. (2005). Quality of life as an outcome measure in alcoholism treatment research. Journal of Studies on Alcohol, S15, 119–139. CrossRef
The EuroQol Group. (1990). EuroQol—a new facility for the measurement of health-related quality of life. Health Policy, 16, 199–208. CrossRef
Falk, D., Wan, X. Q., Liu, L., Fertig, J., Mattson, M., Ryan, M., … Litten, R. Z. (2010). Percentage of subjects with no heavy drinking days: Evaluation as an efficacy endpoint for alcohol clinical trials. Alcoholism: Clinical and Experimental Research, 34(12), 2022–2034. doi: 10.1111/j.1530-0277.2010.01290.x.
François, C., Rahhali, N., Chalem, Y., Sørensen, P., Luquiens, A., & Aubin, H. J. (2015). The effects of as-needed Nalmefene on patient-reported outcomes and quality of life in relation to a reduction in alcohol consumption in alcohol-dependent patients. PLoS ONE, 10(8), e0129289. doi: 10.1371/journal.pone.0129289. CrossRefPubMedPubMedCentral
Gliem, J. A., & Gliem, R. R. (2003). Calculating, interpreting, and reporting Cronbach’s Alpha reliability coefficient for Likert-type scales. In: Midwest Research to Practice Conference in Adult, Continuing, and Community Education, (pp. 82–88). http://www.ssnpstudents.com/wp/wp-content/uploads/2015/02/Gliem-Gliem.pdf.
Hu, L. T., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling, 6, 1–55. CrossRef
IBM Corp. (2015). IBM SPSS Statistics for Windows. Version 23.0. Armonk, NY: IBM Corp.
International Resource Center for Health Care Assessment. (1992). How to score the SF-36 short-form health survey. Boston, MA: The Health Institute.
Jaracz, K., Kalfoss, M., Górna, K., & Bączyk, G. (2006). Quality of life in polish respondents: Psychometric properties of the Polish WHOQOL-BREF. Scandinavian Journal of Caring Science, 20, 251–260. CrossRef
Kaskutas, L. A., Borkman, T. J., Laudet, A., Ritter, L. A., Witdbrodt, J., Subbaraman, M. S., ... Bond, J. (2014). Elements that define recovery: the experiential perspective. Journal of Studies on Alcohol and Drugs, 75, 999–1010. doi: 10.15288/jsad.2014.75.999.
Marlatt, G. A., & Witkiewitz, K. A. (2010). Harm reduction approaches to alcohol use: Health promotion, prevention, and treatment. Addictive Behaviors, 27(6), 867–886. CrossRef
Miller, W. R., Tonigan, J. S., & Longabaugh, R. (1995). The drinker inventory of consequences (DrInC): An instrument for assessing adverse consequences of alcohol abuse. Test manual (Project MATCH Monograph Series, Vol. 4). Rockville, MD: National Institute on Alcohol Abuse and Alcoholism.
Muthén, L.K., & Muthén, B.O. (2012). Mplus users guide (Version 7).
Neale, J., Finch, E., Marsden, J., Mitcheson, L., Rose, D, Strang, J., … Wykes, T. (2014). How should we measure addiction recovery? Analysis of service provider perspectives using online Delphi groups. Drugs: Education, Prevention and Policy, 21(4), 310–323. doi: 10.3109/09687637.2014.918089.
Ohaeri, J. U., Awadalla, A. W., El-Abassi, A. H. M., & Jacob, A. (2007). Confirmatory factor analytical study of the WHOQOL-Bref: Experience with Sudanese general population and psychiatric samples. BMC Medical Research Methodology, 7(1), 37. doi: 10.1186/1471-2288-7-37. CrossRefPubMedPubMedCentral
Trompenaars, F. J., Masthoff, E. D., Van Heck, G. L., Hodiamont, P. P., & De Vries, J. (2005). Content validity, construct validity, and reliability of the WHOQOL-Bref in a population of Dutch adult psychiatric outpatients. Quality of Life Research, 14(1), 151–160. doi: 10.1007/s11136-004-0787-x. CrossRefPubMed
WHOQOL Group. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine, 28, 551–558. CrossRef
Widaman K. F., Ferrer E., & Conger R. D. (2010). Factorial invariance within longitudinal structural equation models: measuring the same construct across time. Child Development Perspectives, 4(1), 10–18. doi: 10.1111/j.1750-8606.2009.00110.x.
World Health Organization. (2015). International classification of diseases, tenth revision, clinical modification (ICD- 10- CM).
- Viability of the World Health Organization quality of life measure to assess changes in quality of life following treatment for alcohol use disorder
Elizabeth R. Stein
Matthew R. Pearson
- Springer International Publishing